Recent Episodes
People undergoing in vitro fertilization or IVF screen have their embryos screened for genetic disease before choosing one. It’s called preimplantation genetic testing.
Now, a new test goes a step further. While genetic screening tests identify mutations that lead to conditions such as Down’s Syndrome and cystic fibrosis, the new test predicts the chances a child might develop diseases such as diabetes, heart disease, breast cancer and even schizophrenia. These are called polygenic diseases which is what can happen when genes interact.
Researchers created the test by analyzing an embryo’s genome for millions of single nucleotide polymorphisms or SNPs. Since SNPs are linked to certain diseases, they can be used to predict an embryo’s risk of developing them. Then people undergoing IVF can choose the healthiest embryo to implant.
Genomic health companies like Orchid sequence over ninety-nine percent of an embryo’s genome, testing for twelve hundred single-gene diseases, fifty missing or duplicate genes, and polygenic risk scores for twelve common diseases such as Alzheimer’s and certain cancers. But keep in mind that the test can’t know whether someone picks up smoking or eats poorly in their lifetime, so the person can still get heart disease even if they weren’t predicted to have it.
And could this technology open the door to designer babies, where parents select for intelligence and looks? Drawing legal lines around this would be a smart move. Either way, we see this becoming a standard part of IVF.
More Information
Silicon Valley wants to help me make a superbaby. Should I let it?
High-powered couples are turning to genetic-testing startups to help “design” their offspring. I decided to take the first steps myself.
Tech execs are paying top dollar to breed smarter babies, report claims
Silicon Valley tech execs are reportedly paying up to $50,000 for a new genetic-testing service that promises to screen embryos for IQ
Medicine...
Medicine is constantly advancing – that is a great thing about life in the 21st century. But it doesn’t just happen. Dedicated biomedical scientists are making discoveries that translate into those new medical advances.
Biomedical science is broad, encompassing everything from social science to microbiology, biochemistry, epidemiology, to structural biology and bioinformatics to name just a few areas. And, it can involve basic fundamental biology, the use of AI and chemistry to clinical studies that evaluate new medicines in patients.
No matter the research focus, the goal is always the same, to advance human health. It may take a few months, a few years or for fundamental science, a few decades. Few people make the connection that biomedical science is medicine and that biomedical scientists are working today on the medicine of tomorrow. Our weekly 500-word newspaper columns and 2-minute radio shows and podcasts provide insights into a broad range of biomedical science topics.
Medical Discovery News is dedicated to explaining discoveries in biomedical research and their promise for the future of medicine.